You are here Home International Operations USA

Accord Healthcare Inc., a wholly owned subsidiary of Intas, in operation since 2007. In a short span, Accord has more than 36 ANDAs approvals and supplied products of various categories like Anti-Cancer, Anti-Diabetic, Lipid lowering agents etc. It's the preferred supplier for leading distributors and retail pharma chains. A healthy product pipeline with about 30+ ANDAs awaiting approval forms the base for a strong future footprint in US market in various therapeutic categories. With a strong R & D support, Accord has filed para IV with FTF status and 505(b)2 application and has a few more in pipeline. The company has more focus on niche segments like hospital and critical care products with special emphasize on oncology, immunosuppressant and other critical care segments.

Going forward Accord aims to create significant presence in market with combination of product portfolio which includes high volume products as well as niche and difficult to develop products.

For more information, click here